Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-07-09 00:00:00 ET · period of report 2024-07-08 · accession 0001649094-24-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-09 | 2024-07-08 | PCVX | Cowan Elvia | SVP, Fin | M - OptEx | $25.92 | +5,000 | 17.7K | +39% | +$129.6K |
| D | 2024-07-09 | 2024-07-08 | PCVX | Cowan Elvia | SVP, Fin | S - Sale+OE | $80.00 | -5,000 | 12.7K | -28% | -$400.0K |
| D | 2024-07-09 | 2024-07-08 | PCVX | Cowan Elvia | SVP, Fin | M - OptEx | $0.00 | -5,000 | 124.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-08 | M | A | 5,000 | $25.92 | 17,723 | D | — | — | (F1) Includes 567 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024. |
| 2 | Common | Common Stock | 2024-07-08 | S | D | 5,000 | $80.00 | 12,723 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-07-08 | M | D | 5,000 | $0.00 | 124,000 | D | $25.92 · — to 2032-08-08 | 5,000 Common Stock | (F3) 1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |